Literature DB >> 9734658

Arsenic induces apoptosis in B-cell leukaemic cell lines in vitro: activation of caspases and down-regulation of Bcl-2 protein.

Y Akao1, H Mizoguchi, S Kojima, T Naoe, N Ohishi, K Yagi.   

Abstract

We showed that arsenic inhibited the cell growth of four B-cell leukaemia cell lines of 11 various cell lines in vitro. In two of these four lines, KOCL44 and LyH7, apoptosis was identified by morphological and nucleosomal DNA fragmentation studies. Three of the four B-cell lines that were growth inhibited were acute infantile leukaemia with t(11;19)(q23;p13) translocations involving the MLL gene that encodes the transcriptional factor Drosophila trithorax. The arsenic-induced apoptosis in KOCL44 and LyH7 cells was found to be linked to caspases by Western blot and enzymological analyses. The amount of Bcl-2 was reduced during apoptosis in LyH7 as judged by Western blot analysis. We concluded that combined activation of the caspases and down-regulation of Bcl-2 could determine the fate of B-cell leukaemic cells in response to arsenic.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9734658     DOI: 10.1046/j.1365-2141.1998.00869.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  20 in total

1.  Arsenite causes down-regulation of Akt and c-Fos, cell cycle dysfunction and apoptosis in glutathione-deficient cells.

Authors:  Geetha M Habib
Journal:  J Cell Biochem       Date:  2010-05-15       Impact factor: 4.429

2.  Trisenox induces cytotoxicity through phosphorylation of mitogen-activated protein kinase molecules in acute leukemia cells.

Authors:  Sanjay Kumar; Ibrahim O Farah; Paul B Tchounwou
Journal:  J Biochem Mol Toxicol       Date:  2018-08-08       Impact factor: 3.642

Review 3.  Arsenic and Immune Response to Infection During Pregnancy and Early Life.

Authors:  Sarah E Attreed; Ana Navas-Acien; Christopher D Heaney
Journal:  Curr Environ Health Rep       Date:  2017-06

4.  mCICR is required for As2O3-induced permeability transition pore opening and cytochrome c release from mitochondria.

Authors:  Xuemei Tian; Xiaodong Ma; Dongfang Qiao; Ande Ma; Fang Yan; Xingxu Huang
Journal:  Mol Cell Biochem       Date:  2005-09       Impact factor: 3.396

5.  Therapeutic Potential of Arsenic Trioxide (ATO) in Treatment of Hepatocellular Carcinoma: Role of Oxidative Stress in ATO-Induced Apoptosis.

Authors:  Erika B Dugo; Clement G Yedjou; Jacqueline J Stevens; Paul B Tchounwou
Journal:  Ann Clin Pathol       Date:  2017-01-04

6.  Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a Wisconsin Oncology Network study.

Authors:  J E Chang; P M Voorhees; J M Kolesar; H G Ahuja; F A Sanchez; G A Rodriguez; K Kim; J Werndli; H H Bailey; B S Kahl
Journal:  Hematol Oncol       Date:  2009-03       Impact factor: 5.271

7.  Basic mechanisms of arsenic trioxide (ATO)-induced apoptosis in human leukemia (HL-60) cells.

Authors:  Clement Yedjou; Paul Tchounwou; John Jenkins; Robert McMurray
Journal:  J Hematol Oncol       Date:  2010-08-26       Impact factor: 17.388

8.  Regulation of arsenic trioxide-induced cellular responses by Mnk1 and Mnk2.

Authors:  Blazej Dolniak; Efstratios Katsoulidis; Nathalie Carayol; Jessica K Altman; Amanda J Redig; Martin S Tallman; Takeshi Ueda; Rie Watanabe-Fukunaga; Rikiro Fukunaga; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2008-02-25       Impact factor: 5.157

9.  Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated inhibition of p73 transcription and prevention of NF-kappaB-mediated induction of XIAP, cIAP2, BCL-XL and survivin.

Authors:  Majid Momeny; Majid Zakidizaji; Reza Ghasemi; Ahmad R Dehpour; Maryam Rahimi-Balaei; Yassan Abdolazimi; Ardeshir Ghavamzadeh; Kamran Alimoghaddam; Seyed H Ghaffari
Journal:  Med Oncol       Date:  2009-09-10       Impact factor: 3.064

Review 10.  Acute lymphoblastic leukemia in adults.

Authors:  M R Litzow
Journal:  Curr Treat Options Oncol       Date:  2000-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.